<DOC>
	<DOCNO>NCT01694225</DOCNO>
	<brief_summary>This study aim establish feasibility use monthly bubble package improve compliance rate among woman prescribe adjuvant endocrine therapy .</brief_summary>
	<brief_title>Adherence Rate Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy Breast Cancer Survivors</brief_title>
	<detailed_description>This study use Bubble packaging provide cost effective way improve compliance help direct intervention ensure adherence woman anti-estrogen therapy breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>18 year age old Estrogen receptor positive ( &gt; 1 % estrogen expression ) immunohistochemistry Invasive breast cancer ( stage I , II , III ) DCIS consider adjuvant endocrine therapy Patients metastatic disease ( stage IV ) Patients less 18 year age Prisoners Patients unable fill prescription BCC pharmacy due insurance limitation personal preference</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Anti-estrogen therapy</keyword>
</DOC>